Filing Details

Accession Number:
0001144204-10-062975
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-22 17:28:51
Reporting Period:
2010-11-18
Filing Date:
2010-11-22
Accepted Time:
2010-11-22 17:28:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1318641 Cleveland Biolabs Inc CBLI Services-Commercial Physical & Biological Research (8731) 200077155
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244745 L Bernard Kasten C/O Cleveland Biolabs, Inc.
73 High Street
Buffalo NY 14203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.005 Per Share Acquisiton 2010-11-18 2,000 $6.10 17,656 No 4 P Indirect See footnote
Common Stock, Par Value $0.005 Per Share Acquisiton 2010-11-19 10,000 $6.15 27,656 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $6.00 2006-07-20 2016-07-19 15,000 15,000 Direct
Common Stock Stock Options (Right to Buy) $9.40 2007-06-12 2017-06-11 35,000 35,000 Direct
Common Stock Stock Options (Right to Buy) $5.88 2008-04-29 2018-04-28 35,000 35,000 Direct
Common Stock Stock Options (Right to Buy) $3.33 2009-06-25 2019-06-24 35,000 35,000 Direct
Common Stock Stock Options (Right to Buy) $2.98 2010-06-08 2020-06-07 35,000 35,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-07-19 15,000 15,000 Direct
2017-06-11 35,000 35,000 Direct
2018-04-28 35,000 35,000 Direct
2019-06-24 35,000 35,000 Direct
2020-06-07 35,000 35,000 Direct
Footnotes
  1. Shares were acquired through a brokerage account in the name of Mr. Kasten's granddaughter. Mr. Kasten has voting and investment power over the shares of common stock held in this brokerage account. As such, Mr. Kasten is deemed to have beneficial ownership of the shares of common stock held through this brokerage account.